AG vs ATR: Which Is the Better Buy in 2026?

Last updated September 2026

Short answer

AG (First Majestic Silver Corp) and ATR (AptarGroup) share investment themes but are different businesses. The right pick is whichever thesis you actually believe, sized so you are not over-concentrated in one theme.

AG vs ATR: the tie-breaker metrics

Same yardstick, side by side (as of September 2026). Valuation lined up like this is most meaningful for two names in the same corner of the market, which these are. Figures are approximate; verify before investing.

MetricAGATRWhat it tells you
Market cap$9.79B$8.32BSize. The larger name is the incumbent; the smaller has more room to grow and more to prove.
Forward P/E19.5220.72Valuation on next year's expected earnings, the same yardstick for both. Lower is cheaper for that growth; higher means the market is paying up.
Trailing P/E28.3723.63Valuation on the last 12 months. A big drop from trailing to forward means the market expects earnings to jump, so more growth is already in the price.
Beta2.110.38Volatility vs the market. Above 1 swings harder than the index; below 1 is steadier. Higher beta means bigger drawdowns to hold through.
Price vs 52-week range47% of range63% of rangeWhere today's price sits between the 52-week low and high. Near the high is momentum with less margin of safety; near the low is out of favor or a discount, depending on why.
Price / book3.303.17How much you pay over book value. Very high can signal an asset-light, high-return business or a rich price.

Before you buy: how AG and ATR affect your concentration

The metrics above tell you which is the marginally better business. The bigger risk for most people is not picking the slightly worse stock, it is over-concentrating. AG and ATR share themes, so owning both, or adding either to what you already hold, can quietly push a large share of your portfolio into one bet.

This is the part a generic comparison page cannot answer, because it depends on what you own. Connect your brokerage and Walnut shows your real, combined AG and ATR exposure, flags overlap with your existing positions, and tells you if adding one would tip you past a concentration you are comfortable with, read-only by default, with your login staying at your broker. Walnut is not an investment adviser.

What does First Majestic Silver Corp (AG) do?

First Majestic Silver Corp. (NYSE: AG) is a precious-metals producer that operates four underground mines in Mexico: San Dimas in Durango, Santa Elena in Sonora, La Encantada in Coahuila, and Cerro Los Gatos in Chihuahua. The company mines silver and gold as its primary products, along with byproduct zinc, lead, and copper. In January 2025 First Majestic completed its roughly $1.05 billion all-stock acquisition of Gatos Silver, adding a 70% interest in the Los Gatos joint venture and lifting 2025 silver production to a record 15.4 million ounces, up about 84% from the prior year.

Full AG guide

What does AptarGroup (ATR) do?

AptarGroup makes the precision dispensing and drug-delivery systems that sit on top of everyday products: nasal spray and inhaler valves for pharma, pumps and airless systems for fragrance and skincare, and dispensing and non-dispensing closures for food, beverage, personal care, and home care. The company runs three reporting segments (Pharma, Beauty, and Closures), with Pharma generating the bulk of profit thanks to long-cycle, regulated, high-margin drug-delivery contracts. Aptar serves a global customer base and positions itself around active material science and delivery precision rather than commodity packaging.

Full ATR guide

AG vs ATR: how do they differ?

Both fit overlapping themes, but they are not interchangeable. The useful comparison is which set of drivers and risks you want exposure to.

  • AG drivers: Silver and gold price leverage; Los Gatos integration and scale.
  • ATR drivers: High-margin pharma drug delivery; Beauty and consumer recovery.

Which fits which kind of investor

A faster-growing, richer-valued name usually swings harder, so it suits a longer horizon and a higher tolerance for volatility; a steadier, more cash-generative business suits a more conservative or income-minded investor. The honest test is which set of risks you could hold through a drawdown: The single largest risk is the silver price itself: a sustained decline would compress margins far faster than the metal falls because mining costs are largely fixed. For ATR, core organic sales have been roughly flat, so headline growth has leaned on acquisitions and currency, which is lower-quality growth.

AG or ATR: which should you pick?

Pick AG if you believe its drivers more; ATR if you believe its. Many investors hold both, but since they share themes, that is a concentrated bet, not diversification. Decide deliberately and check overlap. For the full detail, see the AG and ATR guides.

AG vs ATR: the full fundamentals

AG. First Majestic posted record Q1 2026 revenue of about $476.7 million, up roughly 95% year over year, with net earnings near $128 million and EPS around $0.26 as silver and gold prices surged. The stock trades at a trailing P/E in the low 30s and a forward P/E near 18, reflecting expectations that elevated metal prices continue. The dividend yield is negligible (well under 1%), so the return case rests almost entirely on the metal price and production.

ATR. Aptar trades like a quality defensive industrial: a mid-20s earnings multiple, a low beta near 0.4, and a 30-plus year dividend-growth record. The key valuation tension is paying a premium multiple for a business whose organic sales are currently near flat, so the case depends on pharma mix, margin recovery, and eventual beauty and closures reacceleration.

Headline figures (approximate, Q1 2026): AG shows q1 2026 revenue ~$477M, q1 2026 net earnings ~$128M, q1 2026 eps ~$0.26, q1 2026 free cash flow ~$224M; ATR shows revenue (ttm) ~$3.9B, q1 2026 sales ~$983M (+11% reported, ~flat core), q1 2026 adjusted eps ~$1.19, market cap ~$8.6B.

The bottom line: AG vs ATR

AG and ATR are related but distinct: same themes, different businesses and risks. Neither wins in the abstract; the right pick is whichever thesis you actually believe, sized so you are not over-concentrated in one theme. Walnut can show your combined AG and ATR exposure against your real portfolio. It is not an investment adviser.

Wondering how AG or ATR fits the portfolio you already own? Walnut is an AI investing app that connects your brokerage read-only and answers questions like that about your actual holdings: overlap, concentration, and how each position tracks the S&P 500. Compare the best AI portfolio analyzers or see the best AI investing apps in 2026.

Investing in First Majestic Silver Corp with AI

Connect the broker you already use and ask Walnut's AI how AG fits what you actually hold: whether you own it already through a fund, what it would do to your concentration, and how it has tracked the S&P 500. Read-only by default, and you approve anything before it reaches your broker.

FAQ

What is the difference between AG and ATR?

+

First Majestic Silver Corp. AptarGroup makes the precision dispensing and drug-delivery systems that sit on top of everyday products: nasal spray and inhaler valves for pharma, pumps and airless systems for fragrance and skincare, and dispensing and non-dispensing closures for food, beverage, personal care, and home care. They show up together because they share investment themes, but they are different businesses, so the better fit depends on which thesis you are expressing.

Is AG or ATR the better stock?

+

Neither is universally better; they suit different views and risk levels. Walnut is informational, not investment advice. Compare what each does, the tie-breaker metrics above, and the risks, then decide which fits your thesis and what you already own.

Which is cheaper, AG or ATR?

+

On forward P/E (as of September 2026), AG trades at 19.52x and ATR at 20.72x, so AG is the cheaper of the two on next year's expected earnings. A lower multiple is not automatically the better buy: a richer valuation can be justified by faster growth, and a lower one can reflect real risk. Weigh the multiple against how fast each business is compounding.

Should you own both AG and ATR?

+

Because they share themes, owning both concentrates you in that theme. That can be intentional (a focused bet) or accidental (less diversification than it looks). Walnut can show your combined exposure across both, and whether adding either over-concentrates you, before you buy.

What are the risks of AG vs ATR?

+

AG: The single largest risk is the silver price itself: a sustained decline would compress margins far faster than the metal falls because mining costs are largely fixed. Geographic concentration is severe, with essentially all production in Mexico, exposing the company to peso currency swings, mining royalty and tax changes, permitting delays, and local security or labor disruptions. Rising input costs (energy, labor, consumables) can erode margins even when metal prices are steady. As a smaller producer than majors like Pan American or Fresnillo, AG has less operational diversification to absorb a single mine outage. The stock has historically been highly volatile and can move on sentiment and short interest as much as on fundamentals. ATR: Core organic sales have been roughly flat, so headline growth has leaned on acquisitions and currency, which is lower-quality growth. The planned decline in emergency medicine dispensing sales (about $65 million in 2026) is a known drag on the otherwise strong pharma segment. Beauty and closures are exposed to consumer discretionary weakness, customer destocking, and input-cost swings. Adjusted EBITDA margins have shown compression, and at a P/E near 23 the stock is not cheap for a low-single-digit organic grower. Currency translation adds volatility given the company's large international footprint.

Related comparisons

Browse all stock comparisons.

Walnut is informational, not investment advice. This page is descriptive and not a recommendation to buy or sell AG or ATR; figures are approximate and dated (as of September 2026). Verify current data before investing.